Financial Snapshot

Revenue
$20.18M
TTM
Gross Margin
-11.47%
TTM
Net Earnings
-$20.27M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
185.2%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$10.30M
Q3 2024
Cash
Q3 2024
P/E
-0.1033
Nov 29, 2024 EST
Free Cash Flow
-$33.87M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $7.164M $16.36M $17.26M $8.464M $2.836M $2.170M
YoY Change -56.22% -5.21% 103.96% 198.45% 30.69%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $7.164M $16.36M $17.26M $8.464M $2.836M $2.170M
Cost Of Revenue $10.30M $31.91M $32.93M $15.89M $9.240M $7.510M
Gross Profit -$3.137M -$15.55M -$15.66M -$7.425M -$6.410M -$5.340M
Gross Profit Margin -43.79% -95.01% -90.73% -87.72% -226.02% -246.08%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $14.07M $47.65M $63.52M $50.36M $26.85M $13.33M
YoY Change -70.48% -24.98% 26.15% 87.57% 101.4%
% of Gross Profit
Research & Development $3.482M $28.15M $36.68M $33.45M $15.00M $19.08M
YoY Change -87.63% -23.25% 9.65% 123.03% -21.38%
% of Gross Profit
Depreciation & Amortization $191.0K $6.480M $5.800M $2.800M $2.280M $2.120M
YoY Change -97.05% 11.72% 107.14% 22.81% 7.55%
% of Gross Profit
Operating Expenses $8.591M $76.86M $100.2M $83.81M $41.85M $32.41M
YoY Change -88.82% -23.3% 19.56% 100.28% 29.12%
Operating Profit -$11.73M -$92.41M -$112.1M -$91.33M -$72.57M -$37.75M
YoY Change -87.31% -17.58% 22.76% 25.86% 92.24%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $5.655M -$4.281M $5.677M $5.506M $22.27M -$4.930M
YoY Change -232.1% -175.41% 3.11% -75.27% -551.68%
% of Operating Profit
Other Income/Expense, Net -$130.0K $33.00K -$5.561M -$10.63M -$24.47M -$5.220M
YoY Change -493.94% -100.59% -47.66% -56.58% 368.77%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$11.86M -$39.53M -$117.7M -$102.0M -$97.04M -$47.91M
YoY Change -70.01% -66.41% 15.42% 5.07% 102.54%
Income Tax $63.00K $82.00K $0.00 $23.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$81.66M -$39.62M -$117.7M -$102.0M -$97.04M -$47.91M
YoY Change 106.14% -66.34% 15.39% 5.11% 102.54%
Net Earnings / Revenue -1139.91% -242.11% -681.81% -1205.1% -3421.69% -2207.83%
Basic Earnings Per Share -$2.81 -$1.40 -$4.11 -$8.94
Diluted Earnings Per Share -$2.81 -$1.40 -$4.11 -$8.94 -$3.938M -$1.944M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $22.40M $70.45M $100.8M $131.1M $71.80M $17.70M
YoY Change -68.2% -30.09% -23.13% 82.59% 305.65%
Cash & Equivalents $19.17M $25.58M $24.07M $25.20M $9.500M $9.600M
Short-Term Investments $3.233M $44.86M $76.70M $105.8M $62.40M $8.100M
Other Short-Term Assets $8.218M $13.01M $5.476M $5.200M $2.000M $1.100M
YoY Change -36.82% 137.55% 5.31% 160.0% 81.82%
Inventory $4.278M $13.33M $16.41M $13.00M $8.400M $3.000M
Prepaid Expenses
Receivables $11.35M $21.09M $3.633M $2.200M $300.0K $200.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $46.25M $117.9M $126.3M $151.4M $82.50M $21.90M
YoY Change -60.76% -6.67% -16.59% 83.52% 276.71%
Property, Plant & Equipment $4.014M $13.09M $18.19M $14.00M $6.800M $3.900M
YoY Change -69.34% -28.02% 29.94% 105.88% 74.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $7.120M $8.700M
YoY Change -100.0% -18.16%
Other Assets $3.694M $897.0K $1.152M $700.0K $100.0K $100.0K
YoY Change 311.82% -22.14% 64.57% 600.0% 0.0%
Total Long-Term Assets $7.708M $15.57M $43.50M $41.10M $23.00M $4.000M
YoY Change -50.5% -64.2% 5.84% 78.7% 475.0%
Total Assets $53.96M $133.4M $169.8M $192.5M $105.5M $25.90M
YoY Change
Accounts Payable $2.761M $4.721M $7.519M $8.300M $3.900M $1.600M
YoY Change -41.52% -37.21% -9.41% 112.82% 143.75%
Accrued Expenses $3.605M $10.01M $9.090M $7.900M $10.60M $4.800M
YoY Change -63.97% 10.07% 15.06% -25.47% 120.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $11.30M
YoY Change -100.0%
Long-Term Debt Due $1.864M $1.800M $1.500M $5.400M $8.200M $0.00
YoY Change 3.56% 20.0% -72.22% -34.15%
Total Short-Term Liabilities $18.94M $19.87M $18.51M $21.90M $31.90M $24.90M
YoY Change -4.68% 7.36% -15.48% -31.35% 28.11%
Long-Term Debt $32.65M $34.43M $40.92M $42.90M $43.90M $14.60M
YoY Change -5.17% -15.84% -4.63% -2.28% 200.68%
Other Long-Term Liabilities $3.243M $4.115M $4.641M $1.100M $2.100M $0.00
YoY Change -21.19% -11.33% 321.91% -47.62%
Total Long-Term Liabilities $35.90M $38.55M $45.56M $44.00M $46.00M $14.60M
YoY Change -6.88% -15.38% 3.54% -4.35% 215.07%
Total Liabilities $54.84M $58.42M $64.07M $66.00M $77.90M $39.50M
YoY Change -6.13% -8.81% -2.93% -15.28% 97.22%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 29.10M shares 28.32M shares 28.65M shares 11.41M shares
Diluted Shares Outstanding 28.32M shares 28.65M shares 11.41M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.0939 Million

About Acutus Medical, Inc.

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California and currently employs 233 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES ALR TECHNOLOGIES INC. RemSleep Holdings Inc. DELCATH SYSTEMS, INC. STRATA Skin Sciences, Inc. OMNIA WELLNESS INC. HeartBeam, Inc. MINERVA SURGICAL INC NeuroMetrix, Inc. NEUROONE MEDICAL TECHNOLOGIES Corp